SCHEMBL6707958

SCHEMBL6707958

O=C(Cc1cccc(C(F)(F)F)c1)Nc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 1/20 0.44
CSNK1D P48730 1/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 2/20 0.39
KCNQ2 O43526 1/20 0.38
BRAF P15056 1/20 0.38
PDE5A O76074 1/20 0.37
GPR35 Q9HC97 1/20 0.36
KDR P35968 1/20 0.36
GRIK1 P39086 1/20 0.36
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
RIPK1 Q13546 3/20 0.35
ROCK2 O75116 1/20 0.35
TEK Q02763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711736 0.94 GPR35 (0.38) PARP14MAPTRXFP1GPR35GRIK1
SCHEMBL6707717 0.91 PARP14 (0.44) PARP14CSNK1DMAPTMEN1KMT2A
SCHEMBL6707815 0.90 PARP14 (0.42) PARP14MAPTMEN1KMT2ARXFP1
SCHEMBL6710051 0.90 MEN1 (0.40) PARP14MEN1KMT2AGPR35GRIK1
SCHEMBL6708747 0.89 PARP14 (0.43) PARP14CSNK1DMAPTMEN1KMT2A
SCHEMBL6711931 0.89 L3MBTL1 (0.38) MAPTMEN1KMT2ARXFP1KCNQ2
SCHEMBL6709181 0.89 GRIK1 (0.44) CSNK1DMAPTMEN1KMT2AKCNQ2
SCHEMBL6709043 0.88 GRIK1 (0.37) MEN1KMT2AGRIK1PPARGPPARD
SCHEMBL6710077 0.88 CASP3 (0.38) MAPTMEN1KMT2ARXFP1GPR35
SCHEMBL6713651 0.88 MEN1 (0.44) MEN1KMT2AGRIK1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885CSNK1D 4268/4885MAPT 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.